Indications and Purposes
| 1 Indications And Usage Camptosar Is Indicated As A Component Of First-Line Therapy In Combination With 5-Fluorouracil (5-Fu) And Leucovorin (Lv) For Patients With Metastatic Carcinoma Of The Colon Or Rectum. Camptosar Is Indicated For Patients With Metastatic Carcinoma Of The Colon Or Rectum Whose Disease Has Recurred Or Progressed Following Initial Fluorouracil-Based Therapy. Camptosar Is A Topoisomerase Inhibitor Indicated For: First-Line Therapy In Combination With 5-Fluorouracil And Leucovorin For Patients With Metastatic Carcinoma Of The Colon Or Rectum. ( 1 ) Patients With Metastatic Carcinoma Of The Colon Or Rectum Whose Disease Has Recurred Or Progressed Following Initial Fluorouracil-Based Therapy. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Irinotecan Hydrochloride |
|
ZINC1612996 |